Pfizer says it won't make an offer for British drugmaker AstraZeneca
NEW YORK, - Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca.
The announcement Monday comes a week after AstraZenecaâ€™s board rejected a proposed $119-billion buyout offer from Pfizer, the worldâ€™s second-biggest drugmaker by revenue.
Pfizer Chairman and CEO Ian Read says the companyâ€™s final proposal represented full value for AstraZeneca.
Pfizer, the maker of Lipitor and Viagra, has been courting No. 8 AstraZeneca since January, saying their businesses would be stronger together.
Pfizer had been waiting for AstraZeneca to engage in merger talks by a Monday deadline.
Pfizer has previously said it would not make a hostile takeover bid directly to AstraZenecaâ€™s stockholders.
Read more Business News
- Construction hampers businessKelowna
- Sex assault trial continuesPenticton / S. Okanagan
- Accused says he didn't act aloneBC
- Bike lanes not parking lanesKelowna
|QHR Technologies Inc||1.19||0.00|
|Anavex Life Sciences||0.25||-0.007|
|Copper Mountain Mining||3.03||+0.02|
|Sunrise Resources Ltd||0.025||0.00|
|Mission Ready Services||0.25||0.00|
There are several things to consider when deciding how much home to buy. 1. Draw up a budget including the new mortgage payments. While the rules used by most lenders require that the mortgage paym...
Photo: ContributedI would call it a joy ride... You see a planned project or business has a destination. It may be an ongoing revenue stream, it may be a business value or an exit strategy. If you don...
Establishing a joint account may seem like a great strategy at first glance. However, there are many factors that must be considered before taking this action. This article will explore the use of &ls...